F D C

F D C Interest Coverage

The Interest Coverage Ratio of F D C (FDC.NS) as of Oct 25, 2026 is 3.39. In the previous year, Interest Coverage Ratio was 3.20 — a change of 5.86% (higher).

Interest Coverage

3.39

YoY

5.86%

Last updated:

Interest Coverage Ratio of F D C is 2025 3.39 . Interest Coverage Ratio of F D C was 2024 3.20 . It decreases by 5.86% higher compared to the previous year.

The F D C Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
5.19 INR
Jan 1, 2019
5.26 INR
Jan 1, 2020
15.62 INR
Jan 1, 2021
3.30 INR
Jan 1, 2022
3.31 INR
Jan 1, 2023
4.83 INR
Jan 1, 2024
3.20 INR
Jan 1, 2025
3.39 INR
The F D C Interest Coverage history
YEARInterest CoverageYoY
3.39+5.86%
3.20-33.69%
4.83+46.07%
3.31+0.23%
3.30-78.86%
15.62+196.98%
5.26+1.23%
5.19-58.03%
12.38+41.52%
8.74+106.33%
4.24-19.42%
5.26—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

F D C Stock analysis

What does F D C do? FDC Ltd. generates revenue through the manufacturing and distribution of pharmaceutical generics, formulations, and active pharmaceutical ingredients (APIs). The company produces specialized products such as oral rehydration salts (ORS) and functional foods and beverages, targeting therapeutic segments including anti-infectives, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, and analgesics. Its branded products like Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm are sold to healthcare providers and consumers across these segments. The company's APIs, including Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate, and Timolol Maleate, support its formulation business. FDC Ltd. distributes its products through its manufacturing plants, serving both domestic and international markets with a focus on cost-effective generic medicines and specialized formulations. FDC Ltd. targets healthcare providers, hospitals, and retail pharmacies as key buyers of its branded pharmaceuticals and functional products. The company's product portfolio spans multiple therapeutic areas, with brands like Zifi for respiratory conditions and Electral for rehydration, catering to diverse consumer needs in the Indian pharmaceutical market. F D C is one of the most popular companies on Eulerpool.

Frequently Asked Questions about F D C stock

Interest Coverage Ratio of F D C is 3.39 in 2025.

Interest Coverage Ratio of F D C changed from 3.20 to 3.39, representing a 5.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio F D C since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's F D C with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — F D C

All Key Metrics — F D C